版本:
中国

BRIEF-Kite Pharma presents promising preclinical data from Kite-585

April 4 Kite Pharma Inc:

* Kite Pharma - presents promising preclinical data from Kite-585, phase 1 clinical study of Kite-585 in patients with multiple Myeloma planned for 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐